Peter D. Haytaian
Known title: EVP & Pres., DBG & IngenioRxCIK: 0001608538
Associated companies
Transaction History
| ELV | ▼ Sell | Tax Withholding | 446 | $127K | 3/3/2026 | View on chart |
| ELV | ▼ Sell | Tax Withholding | 1,201 | $353K | 3/2/2026 | View on chart |
| ELV | ▲ Buy | Grant | 2,865 | $0 | 3/2/2026 | View on chart |
| ELV | ▼ Sell | Tax Withholding | 2,281 | $902K | 3/3/2025 | View on chart |
| ELV | ▲ Buy | Grant | 3,035 | $0 | 3/3/2025 | View on chart |
| ELV | ▲ Buy | Grant | 4,213 | $0 | 3/3/2025 | View on chart |
| ELV | ▼ Sell | Tax Withholding | 1,649 | $683K | 11/1/2024 | View on chart |
| ELV | ▲ Buy | Grant | 3,799 | $0 | 11/1/2024 | View on chart |
| ELV | ▲ Buy | Option Exercise | 15,000 | $2.5M | 3/4/2024 | View on chart |
| ELV | ▼ Sell | Open Market | 1,889 | $945K | 3/4/2024 | View on chart |
| ELV | ▼ Sell | Open Market | 15,000 | $7.5M | 3/4/2024 | View on chart |
| ELV | ▼ Sell | Open Market | 4,206 | $2.1M | 3/4/2024 | View on chart |
| ELV | ▼ Sell | Tax Withholding | 4,314 | $2.2M | 3/1/2024 | View on chart |
| ELV | ▲ Buy | Grant | 2,405 | $0 | 3/1/2024 | View on chart |
| ELV | ▲ Buy | Grant | 9,152 | $0 | 3/1/2024 | View on chart |
| ELV | ▼ Sell | Tax Withholding | 154 | $69K | 11/1/2023 | View on chart |
| ELV | ▼ Sell | Tax Withholding | 5,469 | $2.6M | 3/2/2023 | View on chart |
| ELV | ▲ Buy | Grant | 2,292 | $0 | 3/1/2023 | View on chart |
| ELV | ▲ Buy | Grant | 9,716 | $0 | 3/1/2023 | View on chart |
| ELV | ▼ Sell | Tax Withholding | 607 | $285K | 3/1/2023 | View on chart |
| ELV | ▼ Sell | Tax Withholding | 200 | $109K | 11/1/2022 | View on chart |
| ELV | ▲ Buy | Option Exercise | 1,848 | $244K | 3/10/2022 | View on chart |
| ELV | ▼ Sell | Open Market | 2,170 | $995K | 3/10/2022 | View on chart |
| ELV | ▼ Sell | Open Market | 4,274 | $2.0M | 3/10/2022 | View on chart |
| ELV | ▼ Sell | Open Market | 4,105 | $1.9M | 3/10/2022 | View on chart |
| ELV | ▼ Sell | Open Market | 5,874 | $2.7M | 3/10/2022 | View on chart |
| ELV | ▼ Sell | Open Market | 1,240 | $574K | 3/10/2022 | View on chart |
| ELV | ▼ Sell | Open Market | 40 | $19K | 3/10/2022 | View on chart |
| ELV | ▼ Sell | Tax Withholding | 493 | $229K | 3/2/2022 | View on chart |
| ELV | ▲ Buy | Grant | 2,215 | $0 | 3/1/2022 | View on chart |
| ELV | ▼ Sell | Tax Withholding | 4,667 | $2.1M | 3/1/2022 | View on chart |
| ELV | ▲ Buy | Grant | 8,250 | $0 | 3/1/2022 | View on chart |
| ELV | ▲ Buy | Grant | 1,167 | $0 | 11/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Elevance Health Q3 Outlook: Premium Pressures and Sector Peer Trends
Elevance Health is preparing for its third-quarter earnings report, with analysts examining key metrics and the potential impact of lower premiums on the company's results. Broader sector news highlights peers like UnitedHealth, Centene, and Oscar Health pursuing growth and cost-saving strategies amidst shifting premium dynamics. The market is observing how these competitive and industry-wide pressures will align with Elevance Health's upcoming performance.
Elevance Health Q3 Outlook: Premium Pressures and Sector Peer Trends. Elevance Health is preparing for its third-quarter earnings report, with analysts examining key metrics and the potential impact of lower premiums on the company's results. Broader sector news highlights peers like UnitedHealth, Centene, and Oscar Health pursuing growth and cost-saving strategies amidst shifting premium dynamics. The market is observing how these competitive and industry-wide pressures will align with Elevance Health's upcoming performance.